IL17A and rheumatoid arthritis: IL‐17 plays a key role in the progression of rheumatoid arthritis in the TMJ, amplifying inflammation by stimulating the release of other pro‐inflammatory cytokines (such as TNF‐α, IL‐6, and IL‐1β), chemokines, and matrix metalloproteinases [18].